For Our Future: Investment Opportunity 2026–2030

Gavi's 2026–2030 strategy

Gavi’s Investment Opportunity (IO) outlines plans for the Vaccine Alliance to protect 500 million children, saving over 8 million lives between 2026 and 2030. While Gavi vaccinated 1 billion children between 2000 and 2020, Gavi will accelerate its impact in the years to come, leveraging the latest innovations in vaccines and vaccine delivery to protect the next billion children in half the time as the first, and against more diseases than ever before.

Ask

  • While Gavi vaccinated 1 billion children between 2000 and 2020, Gavi will accelerate its impact in the years to come, leveraging the latest innovations in vaccines and vaccine delivery to protect the next billion children in half the time as the first, and against more diseases than ever before.
  • Achieving this historic milestone will require effort from all of Gavi’s stakeholders, with donors being asked to provide at least US$ 9 billion in new funding.

Investment Opportunity

A fully funded Gavi will enable the Alliance to achieve the following between 2026–2030:

  • Immunise at least 500 million more children, including an estimated 300 million children in Africa
  • Save an additional 8–9 million lives
  • Catalyse over US$ 4 billion of financial contributions through domestic co-financing and self-funded vaccine programmes
  • Stand ready to respond to 150 disease outbreaks to boost global health security and protect against the threat of future pandemics
  • Reduce prices across at least 50% of Gavi's vaccine portfolio, generate up to US$ 800 million of efficiency savings
  • Generate at least US$ 100 billion in economic benefits for Gavi implementing countries
  • Facilitate over 1.4 billion individual contacts between families and health services, enabling more integrated primary health care and Universal Health Coverage
  • Save 1.5 million lives through the HPV vaccine by protecting girls against cervical cancer
  • Vaccinate over 50 million children against malaria

Resources

About Gavi, the Vaccine Alliance

What is Gavi?

  • Gavi, the Vaccine Alliance was established in 2000 as a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases.
  • Gavi’s mission is to save lives and protect people’s health by increasing equitable and sustainable use of vaccines.
  • Gavi plays a key role in improving global health security by supporting health systems and funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines.
  • Gavi is focused on protecting the next generation, above all the zero-dose children who have not been reached by routine immunisation services.

What is Gavi’s impact?

  • Helped to immunise over 1 billion children since 2000 and has supported more than 1.8 billion vaccinations globally through preventive vaccination campaigns.
  • This has helped to reduce vaccine-preventable child deaths by 70% in Gavi-supported lower-income countries; avert 18.8 million future deaths; and halve mortality among children aged under five.
  • An outbreak and pandemic response organisation supporting global health security:
    • Global stockpiles for yellow fever, Ebola, cholera and meningococcal vaccines – with others planned
    • 2 billion COVID-19 vaccines to 146 economies helping avert an estimated 2.7 million deaths in AMC lower-income participating economies through COVAX
    • Day Zero Pandemic Financing Facility for Vaccines to ensure critical funding for future responses
  • Made vaccines cheaper and more accessible: The cost of fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines has fallen by approximately 60% since 2010.
  • Supported 19 countries to transition to fully self-financing their immunisation programmes. Over US$ 1.7 billion in co-financing contributions from Gavi-supported countries since 2008.
  • Protects against 20 infectious diseases, up from 6 during the 2001–2005 period.
  • Delivered US$ 250 billion in economic benefits through immunisation programmes in Gavi-supported lower-income countries.

What is Gavi’s 2026–2030 Investment Opportunity?

  • Gavi’s Investment Opportunity (IO) outlines the projected impact of the Alliance’s programmes from 2026 to 2030 and how much funding is required to achieve these goals.
  • The IO looks at the number of children who could be vaccinated, lives that could be saved, growing number of diseases against which vaccines are now available and other factors such as:
    • Expanded stockpiles to cope with expected increases in disease outbreaks
    • Key emergency response mechanisms to contain emerging health threats
    • The impact of climate change
    • The economic benefits of immunisation
  • The Investment Opportunity makes the case to the global community, particularly donors, that investment in immunisation is one of the most cost-effective and impactful interventions for health and economic development.

Key messages

Overarching messages

  • Since its inception 25 years ago, Gavi, the Vaccine Alliance has protected a whole generation – over 1 billion children – against infectious diseases, helping to halve child mortality in the countries it supports. Today, Gavi ensures more than half the world’s children have access to life-saving vaccines each and every year.
  • Thanks to Gavi’s work, over 18 million deaths have been averted, sparing millions of families the suffering of losing a child.
  • With vaccinated children more likely to attain an education and live a longer, more productive life, Gavi’s work at scale helps build healthier societies, stronger economies and a better future for all of us.
  • Gavi’s work keeps us all safe from some of the world’s deadliest diseases. The Vaccine Alliance is a vital part of our global defence mechanism against outbreaks, epidemics and pandemics.
  • Gavi has achieved this remarkable, life-saving impact by doing development differently. Its unique Alliance model is founded on the belief that we are far stronger together than apart, with all partners contributing their fair share – including the countries Gavi serves.
  • This is not a traditional ‘charity’ model; this is an empowerment model. All countries pay a share of the cost of their Gavi-supported vaccines. As a country’s income grows, its co-financing payments increase to eventually cover 100% of the costs of their own vaccine programmes. The ultimate goal is for all countries to reach this stage – and for Gavi to put itself out of business.
  • Now, in 2025, Gavi is facing its most ambitious, its most exciting, period yet. With implementing countries committed to funding nearly 50% of the costs of their vaccines over the next five years, it needs a broad coalition of donors – governments, the private sector and foundations – to ensure it is fully funded to meet its ambitious objectives and make our world safer, healthier and more prosperous for everyone:
    • To reach 500 million more children with life-saving vaccines, saving an additional 8–9 million lives.  
    • To enable Gavi to respond to over 150 outbreaks, its largest investment in health security in response to the twin threats of climate change and antimicrobial resistance. 
    • To reach 50 million children with malaria vaccines; protect at least 120 million girls with the HPV vaccine, which protects against the main causes of cervical cancer; and to take the fight to other diseases like dengue and tuberculosis as new vaccines become available.
    • To generate at least US$ 100 billion in economic benefits, helping countries to grow and become more self-sufficient. 

What’s at risk:

  • To stop funding Gavi now would be to lose decades of progress and set the world on a dangerous trajectory of increasing vulnerability against an upturn in outbreaks of deadly, yet preventable, diseases.

Doing development differently

  • The founding principle of Gavi is that we are far stronger together than apart. Its alliance model is unique, designed to bring the unique comparative advantages of partners to protect children from preventable diseases efficiently and effectively.
  • This means bringing together the expertise and reach of the global health community, the implementing power of partner governments, the resources and support of donor governments and foundations, the community-level knowledge and advocacy of civil society, and the innovation and know-how of the private sector. Together, it has achieved much more than it could have by acting alone.
  • Our empowerment model has already helped 19 countries transition from Gavi support so that they now fund 100% of their own vaccine programmes. More will follow, and over the next five years, Gavi-supported countries will pay almost 50% of the cost of their vaccine programmes. This is about sustainability and sovereignty: Gavi support is a hand up, not a handout.

What’s at risk:

  • Gavi’s impressive progress in helping to build countries’ self-sufficiency and resilience is at a crucial juncture: cutting vital support now could set countries backward on their trajectory and make our world a more dangerous place. We need a fully funded Gavi to see its mission through to completion.

Keeping us all safe

  • Gavi helps keep us all safe from some of the world’s deadliest diseases. The Vaccine Alliance is a vital, fundamental part of our global defence mechanism against outbreaks, epidemics and pandemics.
  • As we now know all too well, diseases do not respect borders. Vaccines are often our first line of defence, stopping the spread of an infection locally before it becomes a health crisis globally.
  • This is why Gavi funds the global vaccine stockpiles against deadly infections like Ebola, cholera and yellow fever. It stepped up during the COVID-19 pandemic to help deliver vaccines rapidly and successfully across the globe.
  • Right now, Gavi is helping to fight mpox outbreaks across Africa. As the largest provider of mpox vaccines globally, Gavi is using its know-how gained during COVID-19 on the frontline of the world’s latest health emergency.
  • Gavi-supported vaccination campaigns and routine introductions have virtually eliminated meningitis A in Africa, and with new technology coming online, the prospect of eliminating all strains of meningitis globally is within reach. We have the tools in place to make investments in global health security more effective than ever.

What’s at risk:

  • If Gavi doesn’t meet its funding targets, difficult trade-offs will have to be made between protecting children by maintaining routine immunisation services and protecting our world by fighting outbreaks through our global stockpiles. A world without a fully funded Gavi would be a more dangerous world – for everyone.

The best buy in global health

  • Each vaccination doesn’t just mean a potential life saved, it means parents not having to take time off work to look after their sick child; it means that child is more likely to go to school, to avoid life-changing disabilities and to fulfil a productive life. Multiplying this effect means healthier, more prosperous communities, societies and economies representing nearly half the world’s population.
  • This is why every dollar invested in vaccinations delivers US$ 54 in wider economic benefits – one of the highest returns on investment in global health. In total, Gavi has delivered over US$ 250 billion in economic benefits for the countries it supports since 2000.
  • And this cost-effectiveness goes further – by working as an alliance, Gavi is able to reduce costs and make sure every dollar goes as far as possible in reducing the toll of disease. For every US$ 1 invested in Gavi, 97 cents goes directly to supporting vaccine programmes.

What’s at risk:

  • Given Gavi’s efficiency and low overheads, any reduction in funding cannot fail to have a real-world impact on its ability to save lives, protect our world, and deliver economic growth and sustainability to the countries it supports.

Harnessing the power of the private sector

  • The Vaccine Alliance is unique in that the public and private sectors are equal partners in its mission to protect vulnerable children across the world.
  • This means working in partnership with vaccine manufacturers to ensure healthy markets and maximise cost efficiency. It means harnessing the know-how of logistics experts like UPS, marketing powerhouses like Unilever and tech giants like ARM, among many others. And it means partnering to ensure the latest innovations are employed to serve its mission, from delivering vaccines by drone across Africa to rolling out groundbreaking biometrics in Bangladesh.
  • This work now extends to supporting the sustainable growth of Africa’s vaccine manufacturing base, through Gavi’s African Vaccine Manufacturing Accelerator (AVMA). This new mechanism is designed to both contribute to healthy global vaccine markets, and benefit outbreak and pandemic prevention on the African continent.
  • AVMA is just the latest innovative finance mechanism supporting the Gavi mission. The International Finance Facility for Immunisation (IFFIm) – one key example – has raised US$ 9.7 billion in global capital markets through first-of-their-kind vaccine bonds to fund Gavi programmes.

What’s at risk:

  • No other development organisation leverages the power of the private sector the way Gavi does. Its record in innovative finance, private sector partnerships and market shaping delivers value for money for donors, encourages investment and innovation among manufacturers, and delivers new solutions to address long-standing challenges such as reaching zero-dose children.

The next five years

  • In the coming five years, Gavi’s impact will be greater than ever – protecting more children against more diseases; protecting our world from the threat of pandemics; and protecting communities affected by conflict, climate change and other global challenges.
  • The next five years will also see Gavi generate more economic impact than ever before, helping economies to grow, countries to become self-sufficient and families to prosper.
  • To achieve this impact, Gavi needs at least US$ 9 billion in new donor funding. This is how Gavi, the Vaccine Alliance can contribute to a stronger, safer world for us all in the coming five years.
  • We can do this in partnership with countries, which will fund nearly 50% of the costs of their vaccines as they build and maintain sustainable national immunisation programmes.

Social post suggestions

General

  • We call on donors to invest in @Gavi to support their goals to protect over 500 million children and save over 8 million lives from 2026-2030. #ForOurFuture
  • @Gavi needs at least US$ 9 billion in new donor funding to protect 500 million children and save over 8 million lives between 2026-2030. We urge world leaders to step up and invest #forourfuture
  • Between 2000-2020, @Gavi helped vaccinate more than one billion children, saving over 17 million lives. We urge donors to support Gavi’s 2026-30 goal to protect more children against more diseases faster than ever before
  • Since @Gavi’s inception in 2000, they have helped immunise more than 1.1 BILLION children around the world, averting >18.8 MILLION deaths. We call on donors to invest vital funding to build on this progress
  • From 2000-2023, @Gavi supported 637 vaccine introductions and vaccination campaigns to protect children around the world against 16 infectious diseases! With donor support, Gavi will protect more people, against more diseases, faster than ever before. #forourfuture
  • Thanks to @Gavi-supported vaccination programmes, 1.3 million future deaths were averted in 2023, which translates to over 2 lives saved every minute of the day! We urge donors to fully fund Gavi to continue these lifesaving efforts. #ForOurFuture
  • Investments in immunisation are investments in healthier futures for children around the world. The case for world leaders is clear: fully fund @Gavi #forourfuture https://bit.ly/3KQTvMQ
  • Gavi’s next strategic period up to 2030 calls for the world to invest, immunise and innovate #forourfuture. That’s why we’re supporting @Gavi’s launch of their investment opportunity to usher in a new era of immunisation. https://bit.ly/3KQTvMQ
  • Conflict, #climatechange and mass migration are fueling the risk of deadly outbreaks, which means the world needs @Gavi to be fully funded more than ever before. #ForOurFuture https://bit.ly/3KQTvMQ
  • @Gavi’s launch of their investment opportunity is a critical moment to highlight how funding immunisation secures healthier futures for children around the world. #VaccinesWork to protect communities, contain outbreaks and save lives. #ForOurFuture https://bit.ly/3KQTvMQ
  • For every dollar invested in vaccination, $21 is saved in health care costs, lost wages and lost productivity due to illness and death. As @Gavi launches their investment opportunity and usher in a new era of immunisation, we’re calling for world leaders to fund lifesaving vaccines #ForOurFuture. https://bit.ly/3KQTvMQ
  • Global immunisation efforts have saved at least 154 million lives over the past 50 years! We've seen what's #humanlypossible. Now it's time to build on this progress by fully funding @Gavi at their upcoming replenishment! https://bit.ly/3KQTvMQ

Humanly Possible

  • Immunisation has saved six lives a minute. Every minute. For five decades. Now it’s time for world leaders to invest in immunisation by fully funding @Gavi at their replenishment. #HumanlyPossible https://bit.ly/3KQTvMQ
  • In the last 50 years, immunisation has decreased infant mortality by 40%. That means more children now reach their 5th birthday than ever before. World leaders must build on this incredible progress by funding @Gavi to invest in immunisation and show what is #HumanlyPossible https://bit.ly/3KQTvMQ
  • Vaccines save lives and build futures. We’re proud to work with @Gavi and together we have protected millions of children. But millions still miss out. It’s time to look to the future and fully fund Gavi to invest in the future of immunisation. #HumanlyPossible https://bit.ly/3KQTvMQ

Key hashtags

  • #ForOurFuture
  • #VaccinesWork
  • #HumanlyPossible

Resources

Digital assets

Infographics

  • Infographics from Gavi’s Investment Opportunity: link

Quote cards

  • Quote cards from countries, private sector, civil society and other partners: link

Theme week vignettes

Vignettes spotlighting a unique theme of impact in Gavi implementing countries: link

Country voices

  • Images and quote cards of health workers and people from Gavi implementing countries: link
  • Videos of health workers and people receiving vaccinations: link

Media & content library

  • Photos from pledge announcements: link
  • Photos & B-roll of immunisation in action: link

Voices of support

Quotes and video content of leaders from government, partner organisations, civil society and business expressing why immunisation matters: link

Last updated: 2 May 2025